Skip to content
Blood & Clotting — Direct oral anticoagulantsATC B01AF01

Rivaroxaban

Prescription only

Once-daily blood thinner taken with food.

Starts working
Varies
Half-life
5–9 hours (11–13 in older people)
In use since
2008
Pregnancy
Usually avoided

Overview

Rivaroxaban is a once-daily anticoagulant for atrial fibrillation and clots. The higher doses must be taken with food to be absorbed properly. A low 2.5 mg twice-daily dose is used with aspirin in some heart and leg artery disease.

How it works

Directly blocks the clotting protein factor Xa.

Rivaroxaban belongs to the Direct oral anticoagulants. How Direct oral anticoagulants work: block a single key clotting enzyme (factor Xa or thrombin) directly.

Uses

  • Stroke prevention in atrial fibrillation
  • DVT and pulmonary embolism
  • Clot prevention after joint replacement
  • Coronary and peripheral artery disease (low dose with aspirin)

Available as: tablet, oral suspension.

Typical dose

Adults
AF: 20 mg once a day with the evening meal (15 mg with reduced kidney function).

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Bruising
  • Nosebleeds
  • Heavy periods

Serious — get medical help

Uncommon, but need prompt attention

  • Major bleeding

Warnings

  • Take 15 and 20 mg doses with food
  • Not for mechanical valves or antiphospholipid syndrome

Who should avoid it

  • Active major bleeding
  • Liver disease with clotting abnormalities
  • Mechanical heart valve
  • Taking strong CYP3A4 and P-gp inhibitors (ketoconazole, ritonavir) without review

Interactions

  • NSAIDs, antiplatelets, SSRIs — bleeding
  • Rifampicin, carbamazepine — ineffective
  • Strong CYP3A4 inhibitors — contraindicated

Other medicines in the atlas that need care with Rivaroxaban, grouped by the reason:

High bleeding riskMajorWith Aceclofenac, Celecoxib, Diclofenac, Etoricoxib, Ibuprofen and 7 more

NSAIDs irritate the stomach and affect platelets; with a blood thinner, serious gut bleeding is much more likely.

What's usually done: Avoid NSAIDs; paracetamol is usually the safer painkiller. Ask before using even short courses.

Double anticoagulation — serious bleeding riskMajorWith Alteplase, Apixaban, Dabigatran, Dalteparin, Edoxaban and 6 more

Two blood thinners together greatly increase the risk of major bleeding.

What's usually done: Not taken together except briefly when switching under medical supervision (e.g. heparin to warfarin).

Blood thinner much less effectiveMajorWith Carbamazepine, Efavirenz, Enzalutamide, Griseofulvin, Modafinil and 5 more

Enzyme inducers lower levels of warfarin and DOACs, raising the risk of clots and stroke.

What's usually done: DOACs are usually avoided; warfarin needs close INR monitoring and dose increases (and decreases when the inducer stops).

High bleeding riskMajorWith Aspirin, Cilostazol, Clopidogrel, Dipyridamole, Prasugrel and 1 more

An anticoagulant plus an antiplatelet raises the chance of serious bleeding, including in the gut and brain.

What's usually done: Sometimes prescribed deliberately for a limited time (e.g. after a stent with AF). Don't combine on your own; a stomach-protecting PPI is often added.

More anticoagulant effectMajorWith Itraconazole, Lopinavir-ritonavir, Nirmatrelvir–ritonavir

Combined P-glycoprotein and strong CYP3A4 inhibition can raise apixaban or rivaroxaban exposure and increase bleeding.

What's usually done: Follow the apixaban or rivaroxaban label: avoid or reduce the DOAC dose as directed with strong dual inhibitors.

Increased bleeding riskModerateWith Citalopram, Dapoxetine, Desvenlafaxine, Duloxetine, Escitalopram and 5 more

SSRIs and SNRIs reduce serotonin in platelets, making them less sticky. With blood thinners or NSAIDs, gut bleeding becomes more likely.

What's usually done: Often used together; consider a PPI with NSAIDs, and report bruising, black stools or bleeding.

More anticoagulant effectModerateWith Amiodarone, Ciclosporin, Fluconazole, Verapamil

P-glycoprotein inhibition can raise levels of some oral anticoagulants and increase bleeding.

What's usually done: Check the product label and use an alternative or closer bleeding surveillance when appropriate.

Raised drug levelsModerateWith Clarithromycin, Darunavir, Erythromycin, Voriconazole

Blocking CYP3A4 increases levels of this medicine, so side effects become more likely.

What's usually done: A dose reduction, alternative or extra monitoring may be needed.

Check Rivaroxaban against your own medicines

Using it safely

Alcohol
Best to limit. Alcohol raises bleeding risk.
Food and drink
Take 15 mg and 20 mg doses with the main meal.
If you miss a dose
Take it as soon as you remember the same day; do not double up.
Stopping it
Do not stop without advice: clot risk rises quickly.
Driving
No effect.
Tests and checks
Kidney function yearly; Signs of bleeding
If too much is taken
Bleeding. Seek emergency help; andexanet alfa can reverse it in hospital.
Storage
Room temperature.
Legal status
United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)

Pregnancy and breastfeeding

Pregnancy

Usually avoided

Not used in pregnancy.

Breastfeeding

Usually avoided

Avoid.

Special groups

Kidney disease
Reduce the dose when creatinine clearance is 15–49; avoid below 15.
Liver disease
Avoid in moderate to severe impairment.
Older adults
Higher bleeding risk; check kidney function.

Brand names

United States
Xarelto
United Kingdom
Xarelto
India
Xarelto, Rivaxa
Australia
Xarelto

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Why with food?

On an empty stomach only about two-thirds of a 20 mg dose is absorbed.

Do I need a prescription for Rivaroxaban?

Yes — Rivaroxaban is prescription-only in most countries.

Can I take Rivaroxaban during pregnancy?

Usually avoided. Not used in pregnancy. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.